(Q34034670)

30 July 2017

title

Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin (English)

1 reference

30 July 2017

1 reference

17

Young Chul Sung

1 reference

30 July 2017

Se Jin Im

1

1 reference

30 July 2017

Sang In Yang

2

1 reference

30 July 2017

Se Hwan Yang

3

1 reference

30 July 2017

Dong Hoon Choi

4

1 reference

30 July 2017

So Young Choi

5

1 reference

30 July 2017

Hea Sook Kim

6

1 reference

30 July 2017

Do Soo Jang

7

1 reference

30 July 2017

Kyeong Sik Jin

8

1 reference

30 July 2017

Yo-Kyung Chung

9

1 reference

30 July 2017

Seung-Hee Kim

10

1 reference

30 July 2017

Sang Hoon Paik

11

1 reference

30 July 2017

Yoo Chang Park

12

1 reference

30 July 2017

Moon Koo Chung

13

1 reference

30 July 2017

Yong Bum Kim

14

1 reference

30 July 2017

Kang-Hyun Han

15

1 reference

30 July 2017

Kwan Yong Choi

16

1 reference

30 July 2017

language of work or name

English

0 references

publication date

16 September 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

6

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

e24574

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

copyright license

start time

16 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Erythropoietins: a common mechanism of action

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

A potent erythropoietin-mimicking human antibody interacts through a novel binding site

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Selection, design, and engineering of therapeutic antibodies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Transfection of adherent and suspended cells by calcium phosphate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

VEGF-Trap: a VEGF blocker with potent antitumor effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Optimizing the use of erythropoietic agents-- pharmacokinetic and pharmacodynamic considerations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Determination of domain structure of proteins from X-ray solution scattering

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Engineered antibodies with increased activity to recruit complement

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Multiple roles for the major histocompatibility complex class I- related receptor FcRn

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Activation of erythropoietin signaling by receptor dimerization

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Immunoadhesins: principles and applications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Structural characterization of human erythropoietin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Engineering therapeutic monoclonal antibodies

28 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

IgG2m4, an engineered antibody isotype with reduced Fc function

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

Enhancement of therapeutic protein in vivo activities through glycoengineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

Development and characterization of novel erythropoiesis stimulating protein (NESP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

The immunoglobulin fold family: sequence analysis and 3D structure comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

Control of rHuEPO biological activity: the role of carbohydrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

The effect of molecular weight on the bioavailability of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

Flexibility of human IgG subclasses

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3174958

GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans

29 October 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024574

Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry

21 January 2018

1 reference

12 December 2020

An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties

1 reference

12 December 2020

Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients

1 reference

12 December 2020

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

1 reference

12 December 2020

Maturation of the reticulocyte in vitro

1 reference

12 December 2020

Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells

1 reference

12 December 2020

Survival of recombinant erythropoietin in the circulation: the role of carbohydrates

1 reference

12 December 2020

Validation of an ELISA for determination of antibodies induced in monkeys against Epi-hNE4, a recombinant protein inhibitor of human neutrophil elastase

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease

1 reference

12 December 2020

Monoclonal antibody pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Homodimerization restores biological activity to an inactive erythropoietin mutant

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0024574

Identifiers

DOI

1 reference

30 July 2017

0 references

1 reference

30 July 2017

1 reference